Loading...
$169.2K
Awarded Apr 16, 2026
Competition
FULL AND OPEN COMPETITION
Offers
N/A
Set-Aside
None
Solicitation Type
RFP - Negotiated
Program
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES
Performance Timeline
Start
Jul 15, 2024
Estimated start: Jul 14, 2030
Contract: 75N93026F00001
UEI
MXP1NVQ8C1J8
Parent Company
PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD.
Capabilities & Certifications
Headquarters Location
Current Obligation
$169,160
Base + Exercised Options
$169,160
Total Ceiling Value
$1,887,190
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
Description
A12 - MURINE MODELS OF UTI INFECTION CAUSED BY ANTIBIOTIC-RESISTANT BACTERIA
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier Agency
National Institutes of Health
Sub-tier Agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Funding Agency
Top-tier Agency
National Institutes of Health
Sub-tier Agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Contract Vehicle
75N93024D00017
IDCDepartment of Health and Human Services
Award Type: SINGLE AWARD